Cyrona Cell Podcast: Stem Cell Therapy in Malaysia
Welcome to the Cyrona Cell Podcast, your trusted source for clear, doctor-led conversations about stem cell therapy and regenerative medicine in Malaysia.
Hosted by the team at Cyrona Cell in Kuala Lumpur, this podcast explores how mesenchymal stem cells (MSCs), exosome support, and evidence-informed cell-based care may help patients living with chronic inflammation, immune imbalance, and long-term degenerative conditions.
We discuss:
• How stem cell therapy works in real clinical settings
• What current research supports — and what it does not
• Eligibility and safety screening for treatment
• Conditions such as osteoarthritis, diabetes, neurological disorders, autoimmune diseases, and more
• What international patients can expect when seeking treatment in Malaysia
• Realistic outcomes, risks, and ethical standards in regenerative medicine
At Cyrona Cell, we believe in honest medicine — not hype. Every episode focuses on transparency, medical screening, patient suitability, and integrating cell therapy into a broader treatment plan.
If you are considering stem cell therapy in Kuala Lumpur and want medically grounded information before making a decision, this podcast is designed for you.
New episodes are released regularly.
Cyrona Cell Podcast: Stem Cell Therapy in Malaysia
New Stem Cell Research Targets the Root Cause of Type 1 Diabetes
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
In this episode, we explore a promising new stem cell therapy that could change how type 1 diabetes is treated in the future. Instead of simply managing blood sugar levels, researchers are investigating ways to stop the autoimmune attack that causes the disease in the first place.
You’ll learn:
- How engineered mesenchymal stem cells reversed new-onset type 1 diabetes in mice
- Why researchers are focusing on the immune system rather than just replacing insulin
- The role of alpha-1 antitrypsin (AAT) in protecting insulin-producing beta cells
- How this approach differs from islet transplantation and beta-cell replacement therapies
- Why early treatment may be critical for preserving natural insulin production
- What the latest human clinical trial is studying and how it differs from the mouse research
- How this breakthrough compares to other stem cell therapies for diabetes
- The potential benefits and challenges of bringing this treatment to patients
- What people living with type 1 diabetes should realistically expect today
While this research is still in the early stages and has only shown success in animal models, it offers an exciting look at a future where therapies may address the underlying cause of type 1 diabetes rather than just its symptoms.
Blog Link: New Stem Cell Research Targets the Root Cause of Type 1 Diabetes